What is the recommended dose and dosing frequency of bismuth subsalicylate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bismuth Subsalicylate Dosing for Helicobacter Pylori Eradication

For H. pylori treatment, bismuth subsalicylate is dosed as 2 tablets (524 mg total) four times daily (QID), taken 30 minutes before meals and at bedtime, for 14 days as part of quadruple therapy. 1

Standard Dosing Regimen

The most recent and highest-quality guidelines consistently recommend:

  • Dose per administration: 2 tablets or 2 capsules (524 mg bismuth subsalicylate)
  • Frequency: Four times daily (QID)
  • Timing: 30 minutes before meals and at bedtime
  • Duration: 14 days (not 10 days)
  • Total daily dose: 2,096 mg bismuth subsalicylate

This is given as part of bismuth quadruple therapy, which includes:

  • Bismuth subsalicylate 524 mg QID
  • Tetracycline HCl 500 mg QID (taken 30 minutes after meals)
  • Metronidazole 500 mg QID (taken 30 minutes after meals)
  • PPI twice daily (taken 30 minutes before morning and evening meals)

1

Critical Timing Details

The timing of administration matters significantly:

  • Bismuth and PPI are taken 30 minutes BEFORE meals
  • Antibiotics (tetracycline and metronidazole) are taken 30 minutes AFTER meals

This specific timing has been associated with reliably high cure rates in populations with high antibiotic resistance 1, 2

Duration: Why 14 Days, Not 10 Days

14-day therapy is superior to shorter durations. While the commercial product Pylera® is packaged for 10 days, multiple guidelines demonstrate that 10-14 day regimens achieve significantly higher eradication rates (81.6%) compared to 7-day therapy (68.4%, p<0.01) 3. The 14-day duration is particularly important when metronidazole resistance is present or unknown, as longer duration helps overcome resistance 2.

The 10-day packaging of Pylera® represents a marketing decision rather than optimal clinical practice 1, 2.

Alternative Dosing Schedules

An alternative regimen uses:

  • Bismuth subsalicylate 524 mg QID before meals
  • Tetracycline HCl 500 mg twice daily (BID)
  • Metronidazole 500 mg QID after meals
  • PPI BID

This twice-daily tetracycline dosing may be equally effective and better tolerated, though less extensively studied 1, 2.

Common Pitfalls to Avoid

  1. Don't use 10-day therapy when 14-day is available - The shorter duration was studied for FDA approval convenience, not clinical superiority
  2. Don't ignore meal timing - The specific before/after meal administration may be critical to efficacy
  3. Don't use 7-day regimens - These consistently show inferior results
  4. Don't substitute doxycycline for tetracycline - Results are significantly inferior 1

For Non-H. pylori Indications

For acute diarrhea or upset stomach (per FDA labeling):

  • Adults and children ≥12 years: 2 chewable tablets every 30-60 minutes as needed
  • Maximum: 8 doses (16 tablets) in 24 hours
  • Duration: Do not use for more than 2 days 4

Each tablet contains 262 mg bismuth subsalicylate 4

Safety Considerations

  • Expect blackening of tongue and stools (benign)
  • Monitor for tinnitus (rare at therapeutic doses)
  • Avoid in true penicillin allergy when combined with amoxicillin
  • Contains salicylate (123 mg per tablet) - avoid with aspirin allergy or anticoagulant therapy 4, 5
  • Blood bismuth and salicylate levels remain well below toxic thresholds at recommended doses 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.